/ Not yet recruitingPhase 2/3 Phase II/III, multi-centre, double-blind, parallel assignment, randomized, placebo-controlled study to evaluate the preventive effect of BGP-15 on the hospitalisation of newly diagnosed COVID-19 patients
100 Clinical Results associated with Mitochon Technologies Kft.
0 Patents (Medical) associated with Mitochon Technologies Kft.
100 Deals associated with Mitochon Technologies Kft.
100 Translational Medicine associated with Mitochon Technologies Kft.